University of Maryland Medical System Corporation

President and CEO Dr. Mohan Suntha sets strategic direction for the investment portfolio in coordination with the board's investment committee. The board itself is partially appointed by the governor of Maryland, reflecting UMMS's legacy as a state-created entity. UMMS does not list a dedicated chief investment officer among its public-facing executive leadership.

No — the system does not publish a separate annual investment report akin to a university endowment. Audited consolidated financial statements are released annually and include aggregate balance-sheet assets and long-term investment pools, but specific allocations, manager names, and returns are not broken out for public consumption.

Through the Healthcare Anchor Network, UMMS has committed to place-based impact investing that targets Baltimore neighborhoods and other communities served by its hospitals. The system also directly invests in the real assets it operates — owning rather than leasing its major medical campuses — which blurs the line between operating expenditure and strategic capital allocation.

Governance is separate. The University of Maryland, Baltimore is the academic partner that provides medical staff and research collaboration, and the School of Law is entirely separate. However, the medical system's board and administration are not governed by the university's investment committee. The partnership does create operational entanglement — UMSOM faculty staff the system's flagship hospitals — but the capital pools are distinct.

UMMS was created by state legislation in 1984 to remove the university hospital from direct state control, but the governor appoints several members of the board. The system retains a public mission to serve as a safety-net provider while operating as a private, non-profit corporation, a hybrid status that shapes its investment posture — it can act like an institutional allocator without most of the public-disclosure obligations of a state pension fund.